Bitter tastants induce relaxation of rat thoracic aorta precontracted with high K+

Clinical and Experimental Pharmacology and Physiology

Volumn 41, Issue 4, 2014, Pages 301-308

  Sai, Wen Bo ^a   Yu, Meng Fei ^a   Wei, Ming Yu ^a   Lu, Zhongju ^b   Zheng, Yun Min ^c   Wang, Yong Xiao ^c   Qin, Gangjian ^d   Guo, Donglin ^e   Ji, Guangju ^f   Shen, Jinhua ^a   Liu, Qing Hua ^a  

^a SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES   (China)

^b STONY BROOK UNIVERSITY   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^f INSTITUTE OF BIOPHYSICS   (China)

Author keywords

Bitter tastants; Chloroquine; Intracellular Ca2+; L type Ca2+ channels; Patch clamp; Relaxation

Indexed keywords

CALCIUM ION; CHLOROQUINE; DENATONIUM BENZOATE; NIFEDIPINE; PERTUSSIS TOXIN; POTASSIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CONTROLLED STUDY; DRUG EFFECT; HEART MUSCLE RELAXATION; ISOMETRICS; MUSCLE TONE; MYOGRAPHY; NONHUMAN; PATCH CLAMP TECHNIQUE; RAT; SMOOTH MUSCLE FIBER; THORACIC AORTA; THORACIC AORTIC RING; VASCULAR RING; WISTAR RAT;

BITTER TASTANTS; CHLOROQUINE; INTRACELLULAR CA2+; L-TYPE CA2+ CHANNELS; PATCH CLAMP; RELAXATION;

ANIMALS; AORTA, THORACIC; CALCIUM; CHLOROQUINE; FLAVORING AGENTS; PERTUSSIS TOXIN; POTASSIUM; RATS; RATS, WISTAR; VASOCONSTRICTION; XANTHENES;

EID: 84897872128     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12217     Document Type: Article

References (30)

1. World Health Organization. World Health Statistics 2012. 2012. Available from: http://www.who.int/gho/publications/world_health_statistics/EN_WHS2012_Full.pdf (accessed 7 October 2013).
2. World Health Organization. The World Health Report 2002: Reducing Risks, Promoting Healthy Life. 2002. Available from: http://www.who.int/whr/2002/en/whr02_en.pdf (accessed 8 October 2013).
3. Yu J, Feng HS, Chen BY et al. Protective effects of vasonatrin peptide against hypobaric hypoxia-induced pulmonary hypertension in rats. Clin. Exp. Pharmacol. Physiol. 2010; 37: 69-74.
4. El-Bassossy HM, Abo-Warda SM, Fahmy A. Rosiglitazone, a peroxisome proliferator-activated receptor gamma stimulant, abrogates diabetes-evoked hypertension by rectifying abnormalities in vascular reactivity. Clin. Exp. Pharmacol. Physiol. 2012; 39: 643-9.
5. Nagasawa T, Hye Khan MA, Imig JD. Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib. Clin. Exp. Pharmacol. Physiol. 2012; 39: 454-61.
6. Nguyen H, Odelola OA, Rangaswami J, Amanullah A. A review of nutritional factors in hypertension management. Int. J. Hypertens. 2013; 2013: 1-12.
7. Brown MJ. Science, medicine, and the future. Hypertension. BMJ 1997; 314: 1258-61.
8. Matyas E, Jeitler K, Horvath K et al. Benefit assessment of salt reduction in patients with hypertension: Systematic overview. J. Hypertens. 2011; 29: 821-8.
9. Zhu B, Wang L, Sun L, Cao R. Combination therapy improves exercise capacity and reduces risk of clinical worsening in patients with pulmonary arterial hypertension: A meta-analysis. J. Cardiovasc. Pharmacol. 2012; 60: 342-6.
10. Flynn JT. Management of hypertension in the young: Role of antihypertensive medications. J. Cardiovasc. Pharmacol. 2011; 58: 111-20.
11. Pan Z, Huang J, Cui W, Long C, Zhang Y, Wang H. Targeting hypertension with a new adenosine triphosphate-sensitive potassium channel opener iptakalim. J. Cardiovasc. Pharmacol. 2010; 56: 215-28.
12. Looareesuwan S, White NJ, Chanthavanich P et al. Cardiovascular toxicity and distribution kinetics of intravenous chloroquine. Br. J. Clin. Pharmacol. 1986; 22: 31-6.
13. Musabayane CT, Musvibe A, Wenyika J, Munjeri O, Osim EE. Chloroquine influences renal function in rural Zimbabweans with acute transient fever. Ren. Fail. 1999; 21: 189-97.
14. Abiose AK, Grossmann M, Tangphao O, Hoffman BB, Blaschke TF. Chloroquine-induced venodilation in human hand veins. Clin. Pharmacol. Ther. 1997; 61: 677-83.
15. Anigbogu CN, Adigun SA, Inyang I, Adegunloye BJ. Chloroquine reduces blood pressure and forearm vascular resistance and increases forearm blood flow in healthy young adults. Clin. Physiol. 1993; 13: 209-16.
16. Musabayane CT, Ndhlovu CE, Balment RJ. The effects of oral chloroquine administration on kidney function. Ren. Fail. 1994; 16: 221-8.
17. Jing F, Liu M, Yang N, Liu Y, Li X, Li J. Relaxant effect of chloroquine in rat ileum. Possible involvement of nitric oxide and BKCa. J. Pharm. Pharmacol. 2013; 65: 847-54.
18. Long L, Yang X, Southwood M et al. Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation. Circ. Res. 2013; 112: 1159-70.
19. Lund TC, Kobs AJ, Kramer A et al. Bone marrow stromal and vascular smooth muscle cells have chemosensory capacity via bitter taste receptor expression. PLoS One 2013; 8: e58945.
20. Aziba PI, Okpako DT. Effects of chloroquine on smooth muscle contracted with noradrenaline or high-potassium solutions in the rat thoracic aorta. J. Smooth Muscle Res. 2003; 39: 31-7.
21. Deshpande DA, Wang WC, McIlmoyle EL et al. Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction. Nat. Med. 2010; 16: 1299-304.
22. Zhang CH, Chen C, Lifshitz LM, Fogarty KE, Zhu MS, ZhuGe R. Activation of BK channels may not be required for bitter tastant-induced bronchodilation. Nat. Med. 2012; 18: 648-50.
23. Liu QH, Zheng YM, Korde AS et al. Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 2009; 40: 663-71.
24. 2+ release in smooth muscle. Proc. Natl Acad. Sci. USA 2009; 106: 11418-23.
25. Marcantoni A, Baldelli P, Hernandez-Guijo JM, Comunanza V, Carabelli V, Carbone E. L-Type calcium channels in adrenal chromaffin cells: Role in pace-making and secretion. Cell Calcium 2007; 42: 397-408.
26. Zhang CH, Lifshitz LM, Uy KF, Ikebe M, Fogarty KE, ZhuGe R. The cellular and molecular basis of bitter tastant-induced bronchodilation. PLoS Biol. 2013; 11: e1001501.
27. Pulkkinen V, Manson ML, Safholm J, Adner M, Dahlen SE. The bitter taste receptor (TAS2R) agonists denatonium and chloroquine display distinct patterns of relaxation of the guinea pig trachea. Am. J. Physiol. Lung Cell. Mol. Physiol. 2012; 303: L956-66.
28. Fanchaouy M, Cubano L, Maldonado H, Bychkov R. PKC independent inhibition of voltage gated calcium channels by volatile anesthetics in freshly isolated vascular myocytes from the aorta. Cell Calcium 2013; 54: 257-65.
29. Rajagopal S, Fang H, Oronce CI et al. Site-specific regulation of CA(V)2.2 channels by protein kinase C isozymes betaII and epsilon. Neuroscience 2009; 159: 618-28.
30. Murthy KS, Grider JR, Kuemmerle JF, Makhlouf GM. Sustained muscle contraction induced by agonists, growth factors, and Ca(2+) mediated by distinct PKC isozymes. Am. J. Physiol. Gastrointest. Liver Physiol. 2000; 279: G201-10.